OTC · SONX
Healthcare · Medical - Devices
$1.28
Up+$0.00 (+0.00%)
Updated Oct 11, 2026, 9:55 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · SONX
1M range · 0 trading sessions · Daily adjusted prices
SONX does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning SONX.
Company
Market Activity
Research & News
SONX research
Company profile and research snapshot.
SONENDO INC
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 12, 2024 | Stifel | Hold | — |
| Nov 10, 2023 | Goldman Sachs | Buy | — |
| Nov 9, 2023 | Piper Sandler | Neutral | — |
| Nov 9, 2023 | Goldman Sachs | Buy | — |
| Nov 9, 2023 | Morgan Stanley | Equal-Weight | — |
No generated briefing is available yet.
Yahoo · Sep 21, 2026
LAGUNA HILLS, Calif., September 21, 2026--Sonendo, Inc. ("Sonendo" or the "Company"), a leading dental technology company and developer of the GentleWave® System, today announced that more than two million patients have now been treated with the GentleWave Procedure since its market introduction.
defenseworld.net · Nov 29, 2025
Sonendo, Inc. (NYSE: SONX - Get Free Report) shares rose 3.5% during mid-day trading on Friday. The stock traded as high as $0.26 and last traded at $0.26. Approximately 498 shares were traded during trading, a decline of 62% from the average daily volume of 1,308 shares. The stock had previously closed at $0.2511. Sonendo
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SONX.
No results
No recent SID articles mention SONX.
